Date | Product | Disease | Phase | Company | Therapeutic area |
---|---|---|---|---|---|
2011-12-12 | Blinatumomab (MT103) | acute lymphoblastic leukemia | 2 | Micromet (USA-Germany) | Cancer Oncology |
2011-12-12 | AclarusDx® | Alzheimer\'s disease | observational study | Exonhit (France) | Neurodegenerative diseases |
2011-12-11 | Blinatumomab (MT103) | diffuse large B cell lymphoma | 1 | Micromet (USA-Germany) | Cancer - Oncology |
2011-12-11 | daratumumab (HuMax-CD38) | multiple myeloma |
1-2 | Genmab (Denmark) | Cancer - Oncology |
2011-12-09 | EndoTAG®-1 | triple-negative breast cancer | 2 | MediGene (Germany) | Cancer - Oncology |
2011-12-09 | Alpharadin® (radium-223 chloride) | endocrine-refractory breast cancer patients with bone metastases | 2a | Algeta (Norway) | Cancer - Oncology |
2011-12-09 | BI 201335 | chronic hepatitis C virus | 3 | Boehringer Ingelheim (Germany) | Infectious diseases |
2011-12-08 | Vyvanse® (lisdexamfetamine dimesylate) | adjunctive therapy to primary antidepressant treatment in adults with partial or full remission of recurrent major depressive disorder (MDD) and significant, persistent cognitive impairments |
2 | Shire (UK-USA) | Mental diseases - CNS diseases |
2011-12-08 | linagliptin (Tradjenta® in the US and Trajenta® in Europe) | type 2 diabetes | 3 | Boehringer Ingelheim (Germany) Eli Lilly (USA) | Metabolic diseases |
2011-12-08 | inhaled interferon beta (IFN-beta) | exacerbation-prone asthmatics | 2 | Synairgen (UK) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
2011-12-06 | Lyxumia® (lixisenatide) in combination with Lantus® (insulin glargine) | type 2 diabetes | 3 | Sanofi (France) | Metabolic diseases |
2011-12-06 | APD209 | cancer cachexia |
2a | Acacia Pharma (UK) | Cancer Oncology |
2011-12-06 | BL-1021 | neuropathic pain |
1a | BiolineRx (Israel) | CNS diseases |
2011-12-02 | simeprevir (TMC435) and daclatasvir | genotype-1 chronic hepatitis C virus (HCV) infection |
2 | BMS (USA) Tibotec Pharmaceuticals (J&J) (USA) Medivir (Sweden) | Infectious diseases |
2011-11-28 | blinatumomab (MT103) | acute lymphoblastic leukemia | 2 | Micromet (USA-Germany) | Cancer - Oncology |
2011-11-28 | Eylea® (aflibercept) | neovascular form of age-related macular degeneration (wet AMD) |
3 | Bayer HealthCare (Germany) Regeneron Pharmaceuticals (USA) | Ophtalmological diseases |
2011-11-25 | aerosolised interferon beta (IFN-beta) | viral pneumonia |
preclinical | Synairgen (UK) | Respiratory diseases - Infectious diseases - Lung diseases |
2011-11-24 | tregalizumab (BT-061) | chronic plaque psoriasis |
2 | Biotest (Germany) | Autoimmune diseases - Dermatological diseases |
2011-11-24 | GFT505 | NASH (non-alcoholic steatohepatitis)/NAFLD (non-alcoholic fatty liver disease) | preclinical | Genfit (France) | Liver diseases - Metabolic diseases |
2011-11-24 | PL37 | neuropathic pain |
1 | Pharmaleads (France) | CNS diseases |